https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/news

The Latest

couple on the boardwalk surrounded by seagulls

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

man getting vaccine

Large Scale HIV Vaccine Trial Announced, But PrEP May Challenge Enrollment

Will potential study participants choose a vaccine trial over getting access to PrEP?

Mexico City's Downtown At Twilight

IAS 2019: What to Expect in HIV Science

Next week, 6,000 HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Person picking up prescription from pharmacy

Government Panel Finds PrEP Is Effective, Must Be Available Free of Cost to Patients

The US Preventive Services Task Force released its final ruling in *JAMA*.

Fleur De Kine

New Campaign, Toolkit Gets Providers PrEP'd for Women

New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.

PleasePrEPMe screenshot: St. Louis provider search

New Website Helps People Trying to Navigate Their PrEP Options

A team led by Shannon Weber, M.S.W., has developed PleasePrEPMe, an online PrEP provider search and chat service.

Primary Care Providers Aware of PrEP in NYC Suburbs, but Report Barriers to Prescribing Img

Primary Care Providers Aware of PrEP in NYC Suburbs, but Report Barriers to Prescribing

Anthony J. Santella, Dr.P.H., explains why prevention efforts are lagging within the largest suburban HIV epidemic in the U.S.

illustration of person on cliff with arms raised as sun rises/sets

This Week in HIV Research: From PrEP to Treatment, There's Always More to Learn

April 18, 2019: lamivudine/raltegravir for PrEP; feminizing hormone may impact PrEP efficacy; why TAF has a better renal profile than TDF; the role of internet dating in HIV incidence trends.

This Week in HIV Research: Fentanyl Smooths the Path for HIV

April 4, 2019: what’s driving the HIV outbreak in northeastern Massachusetts; race-gender HIV disparities among Baltimore sex workers; high PrEP interest, low awareness among southern black women; naltrexone implants for opioid dependence.

Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs Img

Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs

Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.